Professor John Babich
Professor John Babich is Founder and Director of Ratio Pharmaceuticals and an international expert in radiochemistry. His extensive experience in the commercialisation of radiopharmaceuticals combined with unparalleled knowledge of radiochemistry will provide a strategic focus on research collaborations.
Professor Babich is a Professor of Radiopharmaceutical Sciences in Radiology. He has spent much of his career devoted to developing novel molecular imaging tools for medical diagnostics and therapeutics with a particular focus on small molecules and peptides.
Prior to joining Weill Cornell Medicine in 2013, John spent 15 years in the pharmaceutical industry. In 1997, he co-founded the company Molecular Insight (acquired by Progenics in 2013) and created a series of radiolabeled small molecules that could be used to visualize and treat prostate cancer.